NASDAQ:BRVE | News | Braveheart Bio, Inc.

BRVE News

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2026-08-07Current reportSEC filingBraveheart Bio, Inc. filed Form 8-KBraveheart Bio, Inc. filed Form 8-K covering items 5.03,9.01.